Author:
Young J,Scherrer AU,Günthard HF,Opravil M,Yerly S,Böni J,Rickenbach M,Fux CA,Cavassini M,Bernasconi E,Vernazza P,Hirschel B,Battegay M,Bucher HC,
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Reference33 articles.
1. HIV/AIDS;Wilson;the management of treatment-experienced HIV-infected patients: new drugs and drug combinations,2009
2. Combating HIV resistance - focus on darunavir;Tremblay;Ther Clin Risk Manag,2008
3. Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2;Clotet;a pooled subgroup analysis of data from two randomised trials,2007
4. Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN;Madruga;a randomised controlled phase III trial,2007
5. Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48;Ortiz;AIDS,2008
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献